Healthy Clinical Trial
Official title:
Effects of Non-invasive Cerebellar Stimulation on Motor Learning and Cortical Electrical Activity of Healthy Individuals
A crossover trial with healthy volunteers will be conducted. Six sessions will be performed once a week in a counterbalanced order and at least with seven days washout period to minimize carry-over effects. In each session, volunteers will be submitted to: fatigue and attention levels evaluation, cortical brain activity measures through paired pulse transcranial magnetic stimulation (pp-TMS), handwriting test, non-invasive cerebellar stimulation during serial reaction time task (SRTT) and performance perception evaluation.
After given prior informed consent, volunteers will be submitted to six pseudo-randomized
sessions using a website (randomization.com) by a non-involved researcher. At study
beginning, volunteers will be evaluated through structured questionnaire and baseline SRTT
will be performed 24 hours before first session. Each session, will comprise the following
experimental sequence:
1. Fatigue and attention levels. It will be measured through an analogue scale graded from
0 to 10, where 0 means lower fatigue or attention levels and 10, the higher fatigue or
attention levels.
2. Short intracortical inhibition (SICI) and intracortical facilitation (ICF): it will be
evaluated through pp-TMS paradigms (Neurosoft, Russia). Initially, rest motor threshold
(RMT) will be determined by finding the lowest stimulator output that elicit motor
evoked potential (MEP) around 50 μV (TMS Motor Threshold Assessment Tool -MTAT 2.0 -
USA). For RMT measure, a figure-eight coil connected to the magnetic stimulator held
manually at 45 degrees from the midline, will be placed over the right primary motor
cortex (C4 - 10/20 System). Subthreshold conditioning stimuli (80% of RMT) and
suprathreshold test stimuli (120% of RMT) will be delivered at an interstimulus interval
(ISI) of 2 milliseconds for SICI and 10 milliseconds for ICF. Ten stimuli will be
applied at each condition (unconditioned pulse and pairs of stimuli with ISI of 2 and 10
milliseconds). Stimuli order delivery will be pseudo-randomized and SICI and ICF will be
expressed as conditioned stimulus percentage regarding unconditioned stimulus.
3. Handwriting test: volunteers will be instructed to write six words with digital pen
using the non-dominant hand on a tablet provided with analysis software system
(MovAlyzer, EUA). The task will be performed spontaneously, without any instruction bias
during writing activity. Each session has different word sequences but the difficulty
level will be maintained (six words, two of them with 4, 6 and 8 letters).
4. Non-invasive cerebellar stimulation + Serial Reaction Time Task: Cerebellar stimulation
will be applied during SRTT (online acquisition).
ctDCS - Electrical current will be delivered through a DC stimulator (NeuroConn Plus,
Germany) using a pair of saline-soaked sponge electrodes (surface 25cm² and 35cm²). The
active electrode (anode or cathode) will be placed over the left cerebellar area (3 cm
lateral to the inion - left cerebellar hemisphere) and the reference, over the right arm
with current intensity of 2mA, fade in and fade out of 10 seconds, during 20 minutes.
Sham tDCS has been used in several studies to evaluate active tDCS effects. Sham ctDCS
will be applied using the same electrodes placement and parameter settings of cathodal
ctDCS however, stimulation will last only 30 seconds but volunteers will be with
electrodes montage for 20 minutes. Because the device will be automatically turned off
without volunteer's perception, early sensations (mild to moderate tingling) on
stimulation site will be experienced without inducing any modulatory effects. Moreover,
after each ctDCS session, an adverse effects questionnaire will be applied.
c-rTMS - Initially, the higher cortical representation area (hotspot) of first dorsal
interosseous (FDI) muscle will be determined through a figure-eight coil connected to
the magnetic stimulator (Rapid², Magstim, UK) held manually and positioned on the scalp
(C4 - 10/20 System) at an angle of 45 degrees from the midline pointed to the target
muscle (FDI). Thereafter, RMT will be measure. Volunteer will be positioned in front of
a computer screen in order to perform SRTT during stimulation. The coil will be placed
over left cerebellar hemisphere (3 cm lateral to the inion) tangentially to the scalp
and pointing upwards. rTMS protocols was based on previous studies and were adjusted to
full-fit safety recommendations and also to be able to realize SRTT simultaneously
(online acquisition). Low frequency protocol: 1Hz, 110% RMT, 1000 stimuli (1 train).
High frequency protocol: 10Hz, 110% RMT, 33 trains, 50 stimuli per train, intertrain
interval of 25 seconds, 1650 stimuli. Sham c-rTMS will be performed with low frequency
protocol using two coils. The first one - connected to the stimulator - will be
positioned on a coil support close to the volunteer but not visible. Therefore,
characteristic stimulation noises will be audible. The second - disconnected to the
stimulator - will be placed over left cerebellar hemisphere. After each c-rTMS session,
presence of adverse effects will be computed.
Serial Reaction Time Task (SRTT): it will be performed through software with visual
stimuli presented on a computer screen in four different positions. Volunteer must
press, with the non-dominant hand, a corresponding key with predetermined fingers as
soon as possible when a highlighted star appears on the screen. The test comprises eight
blocks with 120 trials each. Implicit motor learning is measured by performance changes
between the blocks 5, 6 and 7.
5. Short intracortical inhibition (SICI) and intracortical facilitation (ICF): using the
same RTM as before.
6. Handwriting test.
7. Fatigue and attention levels.
8. Performance perception evaluation: in order to correlate stimulation type to the
conscious improvement on motor task performance (SRTT and handwriting test) will be
asked in the end of each session if the volunteer considers that his motor performance
was better, worse or the same as before.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |